Lv31
366 积分 2025-07-30 加入
Gastric Cancer
1小时前
已关闭
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
2个月前
已完结
A phase 2, open-label study of amivantamab in patients with previously treated advanced or metastatic gastric or esophageal cancer
2个月前
已关闭
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
2个月前
已完结
HRA00129-C004, a Novel c-Met Antibody-Drug Conjugate (ADC), Exerts Encouraging Anti-Tumor Activities and Favorable Safety Profiles
2个月前
已完结
537MO First-in-human study of JNJ-64619178, a protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced cancers
2个月前
已完结
Abstract P044: A phase 1 dose escalation study of protein arginine methyltransferase 5 (PRMT5) brain penetrant inhibitor PRT811 in patients with advanced solid tumors, including recurrent high-grade gliomas
2个月前
已关闭
A phase 1 study of the protein arginine methyltransferase 5 (PRMT5) brain-penetrant inhibitor PRT811 in patients (pts) with recurrent high-grade glioma or uveal melanoma (UM)
2个月前
已关闭
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors
2个月前
已完结
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms
2个月前
已完结
皖公网安备34019202002308
